J. F. Codington

K. Sletten, J. F. Codington, H. Barsett, 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Nucleosides. XXXIV. 1-(2,3,5-Tri-O-trityl-β-D-ribosyl)uracil (2′,3′,5′-tri-O-trityluridine)

J. F. Codington, J. Fox, 1966 .

Reactions with α-Carboxy-4-Chlorostilbene

E. Mosettig, J. F. Codington, 1952 .

Nucleosides. XLI. The conformation of 1,3,4-tri-O-benzoyl-2-deoxy-2-fluoro-β-d-ribose and of 1,3,4-tri-O-benzoyl-2-deoxy-α-(and β-)-d-erythro-pentose☆

R. J. Cushley, J. F. Codington, J. Fox, 1967 .

Nucleosides. XIII. Synthesis of 3'-Amino-3'-deoxy-arabinosyl-uracil via 2',3'-Epoxy-lyxosyl Nucleosides1-3

R. Fecher, J. F. Codington, J. Fox, 1962 .

The Biological Role of Sialic Acid at the Surface of the Cell

R. Jeanloz, J. F. Codington, 1976 .

NUCLEOSIDES. 23. 2',5'-AND 3',5'-EPOXIDES OF PENTOFURANOSYLURACILS.

J. F. Codington, J. Fox, I. Doerr, 1965, The Journal of organic chemistry.

Nucleosides. XLIX. Nuclear magnetic resonance studies of 2′-and 3′-halogeno nucleosides. The conformations of 2′-deoxy-2′-fluorouridine and 3′-deoxy-3′-fluoro-β-D-arabinofuranosyluracil

R. J. Cushley, J. F. Codington, J. Fox, 1968 .

Further studies on the effect of neuraminidase on tumor cell transplantability.

B. Sanford, J. F. Codington, 2008, Tissue antigens.

Comparative lectin-binding and agglutination properties of the strain-specific, TA-3-St, and the non-strain-specific, TA3-Ha, murine mammary carcinoma ascites sublines. Further studies of receptors in epiglycanin.

R. Jeanloz, J. F. Codington, T. Osawa, 1980, Carbohydrate research.

In vivo release of glycoprotein I from the Ha subline of TA3 murine tumor into ascites fluid and serum.

A. G. Cooper, M. Brown, J. F. Codington, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Cell-surface glycoproteins of two sublines of the TA3 tumor.

B. Sanford, R. Jeanloz, J. F. Codington, 1973, Journal of the National Cancer Institute.

NUCLEOSIDES. XXIV. 1-(2',5'-AND 3',5'-EPOXY-BETA-D-LYXOFURANOSYL)URACILS.

J. F. Codington, J. Fox, I. Doerr, 1965, Journal of Organic Chemistry.

Chemical structure of epiglycanin, the major glycoprotein of the TA3-Ha ascites cell. The carbohydrate chains.

V. Reinhold, D. H. van den Eijnden, C. Silber, 1979, The Journal of biological chemistry.

Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybrids.

A. G. Cooper, G. Klein, M. Brown, 1978, Journal of the National Cancer Institute.

Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A.

D. M. Darby, G. Klein, S. Miller, 1983, Cancer research.

Transplantability and antigenicity of two sublines of the TA3 tumor.

B. Sanford, R. Jeanloz, J. F. Codington, 1973, Journal of immunology.

Evidence that the major cell suface glycoprotein of the TA3-Ha carcinoma contains the Vicia graminea receptor sites.

A. G. Cooper, M. Brown, R. Jeanloz, 1975, Biochemistry.

Pyrimidine Nucleosides. VII. Reactions of 2',3',5'-Trimesyloxyuridine1

R. Fecher, J. F. Codington, J. Fox, 1960 .

Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection.

D. M. Darby, G. Klein, S. Miller, 1983, Cancer research.

Pyrimidine Nucleosides. IV. The Synthesis of 1-β-D-Lyxofuranosylthymine1

J. Lampen, L. Kaplan, J. F. Codington, 1958 .

NUCLEOSIDES. XIV. SYNTHESIS OF 2'-DEOXY-2'-FLUOROURIDINE1

A. Bendich, J. F. Codington, J. Fox, 1961 .

Nucleosides. XIX. Structure of the 2'-Halogeno-2'-Deoxypyrimidine Nucleosides1

J. F. Codington, J. Fox, I. Doerr, 1964 .

Pyrimidine Nucleosides. IX. Facile Synthesis of 1-β-D-Lyxofuranosyluracil via 2,3'-Anhydrolyxosyl Intermediates1,2

R. Fecher, J. F. Codington, J. Fox, 1961 .

Nucleosides. XLVI. Selectively methylated derivatives of spongouridine.

R. J. Cushley, J. F. Codington, J. Fox, 1968, Journal of Organic Chemistry.

Nucleosides : XXX. Synthesis of 2-deoxy-2-fluoro-D-ribose

J. F. Codington, J. Fox, I. Doerr, 1966 .

The Synthesis of Cytidine-2-C14-ribosyl-t1

R. Y. Thomson, G. B. Brown, R. Fecher, 1958 .

Nucleosides. XXXV. 1-beta-D-arabinofuranosyl-5-methylcytosine.

J. F. Codington, J. Fox, I. Doerr, 1967, Journal of medicinal chemistry.

Evidence for the presence of an N-acetyllactosamine-type chain in epiglycanin.

D. Frim, R. Jeanloz, J. F. Codington, 1986, Archives of biochemistry and biophysics.

Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell.

G. Klein, S. Miller, J. F. Codington, 1982, Journal of the National Cancer Institute.

Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma.

A. G. Cooper, M. Brown, R. Jeanloz, 1979, Journal of the National Cancer Institute.

The Chemistry of Glycoproteins at the Surfaces of Tumor Cells

R. Jeanloz, J. F. Codington, 1974 .

Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth.

A. G. Cooper, M. Brown, J. F. Codington, 1979, Journal of the National Cancer Institute.

Cell-surface macromolecular and morphological changes related to allotransplantability in the TA3 tumor.

D. Frim, J. F. Codington, 1983, Biomembranes.

Effects of retinoic acid on ascites cells of the TA3 mouse mammary carcinoma

E. Walker‐Nasir, R. Jeanloz, J. F. Codington, 1985, Experientia.

Studies on the possible chemical, immunochemical and morphological differences at the cell surfaces of immunosensitive and immunoresistant, Moloney virus-induced, lymphoma cell-lines.

G. Klein, S. Miller, T. Dalianis, 1983, Carbohydrate research.

Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples

I. Kuter, N. Nikrui, J. F. Codington, 2002, Cancer.

GLYCOPROTEINS AT THE CELL SURFACE OF SUBLINES OF THE TA3 TUMOR

R. Jeanloz, J. F. Codington, 1974 .

STRUCTURAL STUDIES ON THE MAJOR GLYCOPROTEIN OF THE TA3-HA ASCITES TUMOR CELL

R. Jeanloz, J. F. Codington, D. H. V. D. Eijnden, 1978 .

Isolation and partial characterization of surface components of cell line MDA-MB-231 derived from a human metastatic breast carcinoma.

E. Walker‐Nasir, T. Fuller, R. Jeanloz, 1982, Journal of the National Cancer Institute.

Antimalarials; 7-chloro-4-hydroxy- and 4,7-dichloro-1-methylcarbostyrils.

J. F. Codington, R. Lutz, 1946, Journal of the American Chemical Society.

Antibody to epiglycanin and radioimmunoassay to detect epiglycanin-related glycoproteins in body fluids of cancer patients.

K. Bloch, V. P. Bhavanandan, R. Jeanloz, 1984, Journal of the National Cancer Institute.

Unequivocal evidence for a β‐D‐configuration of the galactose residue in the disaccharide chain of epiglycanin, the major glycoprotein of the TA3‐Ha tumor cell

D. H. van den Eijnden, R. Jeanloz, J. F. Codington, 1979, FEBS letters.

Glycoprotein coat of the TA 3 cell. I. Removal of carbohydrate and protein material from viable cells.

B. Sanford, R. Jeanloz, J. F. Codington, 1970, Journal of the National Cancer Institute.

Antimalarials; 6- and 7-chloro-alpha-(dialkylaminomethyl)-4-quinolinemethanols.

J. F. Codington, N. Leake, R. Lutz, 1947, Journal of the American Chemical Society.